ISIS 702843 clinical trials

A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients with Phlebotomy Dependent Polycythemia Vera (PD-PV)

This study looks at a new medicine for people with polycythemia vera. It aims to see if the medicine can reduce how often patients need blood removed (phlebotomy) and to check if it's safe and well-tolerated.